At a glance
- Originator sigma-tau SpA
- Class Antihypertensives
- Mechanism of Action Dopamine receptor agonists; Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Immunological disorders
Most Recent Events
- 15 Dec 1995 New profile for Immunological Disorders.
- 15 Dec 1995 Discontinued-Preclinical for Immunological disorders in Italy (Unknown route)